Trump Hints EU Trade Deal Decision This Weekend; Key Sectors...
Key Takeaways A critical deadline of 1 August 2025 looms for an EU-US trade deal, with the US threatening a 30% tariff on EU imports if no agreement is reached....
Key Takeaways A critical deadline of 1 August 2025 looms for an EU-US trade deal, with the US threatening a 30% tariff on EU imports if no agreement is reached....
Key Takeaways Analyst price targets for Rocket Lab have seen sharp upward revisions in 2025, with major firms like Bank of America and Citi setting targets as high as $50...
Key Takeaways Jeff Bezos completed the sale of 25 million Amazon (AMZN) shares in July 2025, generating approximately $5.65 billion pre-tax. The divestment was part of a pre-announced 10b5-1 trading...
Explore GeoVax Labs’ promising potential in the biotech arena, focusing on groundbreaking vaccines and immunotherapies. With innovative platforms targeting niche markets, such as Mpox and COVID-19 in immunocompromised patients, the...
Key Takeaways Anthropic is reportedly in early discussions for a new funding round that could value the company at over $150 billion, more than doubling its $61.5 billion valuation from...
The United States Department of Defence (DoD) stands at a critical juncture in its quest to secure redundant global positioning, navigation, and timing (PNT) capabilities. With the ever-present risk of...
Key Takeaways PDD Holdings stock has declined significantly by 33.4% through 2024, prompting questions about its potential for a recovery in 2025. The primary drags on performance include macroeconomic headwinds...
Key Takeaways The US President holds broad constitutional power to grant pardons for federal offences, a power now central to discussions surrounding Ghislaine Maxwell. While legally permissible, pardoning Maxwell carries...
Key Takeaways A significant stock purchase in White Mountains Insurance Group (WTM) by a member of the House Financial Services Committee has drawn attention to the ongoing debate around congressional...
Key Takeaways Valuation Disparity: Evoke Pharma’s cash balance of approximately $11.3 million exceeds its market capitalisation, which has dipped below $10 million, suggesting the market is valuing its core operations...
CTA Content